FDA approves controversial women’s libido drug
The FDA approved Vyleesi, an under-the-skin injection women take before sex. Skeptics balk at the idea of a drug playing a role in sexual desire.
The Food and Drug Administration approved a controversial drug meant to increase women’s desire for sex, a treatment that has rekindled a debate over the limits of medicine when it comes to human sexuality.
The drug, called Vyleesi, is an, or HSDD, which is defined as a distressing loss of interest in sex.
